 |
0 Diseases |  |
4 Trials |
|
4 Trials |  |
19 News |  |
- || naltrexone SR implant (BICX104) / BioCorRx
Trial completion: Pharmacokinetic and Safety Study of Naltrexone Release From Subcutaneous BICX104 Pellets Compared to Vivitrol Injections (clinicaltrials.gov) - Mar 28, 2023
P1, N=24, Completed, Sponsor: BioCorRx Inc
Active, not recruiting --> Completed
- || naltrexone SR implant (BICX104) / BioCorRx
Enrollment closed: Pharmacokinetic and Safety Study of Naltrexone Release From Subcutaneous BICX104 Pellets Compared to Vivitrol Injections (clinicaltrials.gov) - Feb 8, 2023
P1, N=24, Active, not recruiting, Sponsor: BioCorRx Inc
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- || naltrexone SR implant (BICX104) / BioCorRx
Enrollment open, Trial completion date, Trial primary completion date: Pharmacokinetic and Safety Study of Naltrexone Release From Subcutaneous BICX104 Pellets Compared to Vivitrol Injections (clinicaltrials.gov) - May 2, 2022
P1, N=24, Recruiting, Sponsor: BioCorRx Inc
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting | Trial completion date: Feb 2022 --> Mar 2023 | Trial primary completion date: Feb 2022 --> Dec 2022
- || naltrexone SR implant (BICX102) / BioCorRx
$BICX BioCorRx Announces Submission of IND Application to the FDA for BICX104, Implantable Naltrexone https://t.co/mxHWKCM0iU (Twitter) - Apr 13, 2021
- | naltrexone SR implant (BICX104) / BioCorRx
New P1 trial: Pharmacokinetic and Safety Study of Naltrexone Release From Subcutaneous BICX104 Pellets Compared to Vivitrol Injections (clinicaltrials.gov) - Apr 1, 2021
P1, N=24, Not yet recruiting, Sponsor: BioCorRx Pharmaceuticals, Inc.